Abstract
Objective: The Diagnostic and statistical manual of mental disorders, third edition (DSM-III), published by the American Psychiatric Association (APA) in 1980, included the first official definitions by the APA of tobacco dependence and tobacco withdrawal. Tobacco industry efforts to influence the DSM-III were investigated.
Method: Searches of previously secret tobacco industry documents, primarily the University of California San Francisco Legacy Tobacco Documents Library and British American Tobacco collections. Additional information was collected through discussions with editors of DSM-III, and library and general internet searches.
Results: The tobacco companies regarded the inclusion of tobacco dependence as a diagnosis in DSM-III as an adverse event. It worked to influence the content of the DSM-III and its impact following publication. These efforts included public statements and private lobbying of DSM-III editors and high ranking APA officers by prominent US psychiatrists with undisclosed ties to the tobacco industry. Following publication of DSM-III, tobacco companies contracted with two US professors of psychiatry to organise a conference and publish a monograph detailing controversies surrounding DSM-III.
Conclusions: The tobacco industry and its allies lobbied to narrow the definition of tobacco dependence in serial revisions of DSM-III. Following publication of DSM-III, the industry took steps to try to mitigate its impact. These actions mirror industry tactics to influence medical research and policy in various contexts worldwide. Such tactics slow the spread of a professional and public understanding of smoking and health that otherwise would reduce smoking, smoking induced disease, and tobacco company profits.
Full Text
The Full Text of this article is available as a PDF (121.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnoya J., Glantz S. Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the "Latin Project". Tob Control. 2002 Dec;11(4):305–314. doi: 10.1136/tc.11.4.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bero L. A., Galbraith A., Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23;271(8):612–617. [PubMed] [Google Scholar]
- Bero L., Barnes D. E., Hanauer P., Slade J., Glantz S. A. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):241–247. [PubMed] [Google Scholar]
- Francey N., Chapman S. "Operation Berkshire": the international tobacco companies' conspiracy. BMJ. 2000 Aug 5;321(7257):371–374. doi: 10.1136/bmj.321.7257.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hong Mi-Kyung, Bero Lisa A. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ. 2002 Dec 14;325(7377):1413–1416. doi: 10.1136/bmj.325.7377.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jaffe J. H. Tobacco use as a mental disorder: the rediscovery of a medical problem. NIDA Res Monogr. 1977 Dec;(17):202–219. [PubMed] [Google Scholar]
- Ong E. K., Glantz S. A. Constructing "sound science" and "good epidemiology": tobacco, lawyers, and public relations firms. Am J Public Health. 2001 Nov;91(11):1749–1757. doi: 10.2105/ajph.91.11.1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slade J., Bero L. A., Hanauer P., Barnes D. E., Glantz S. A. Nicotine and addiction. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):225–233. [PubMed] [Google Scholar]
- Yach D., Bialous S. A. Junking science to promote tobacco. Am J Public Health. 2001 Nov;91(11):1745–1748. doi: 10.2105/ajph.91.11.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]